SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
SEC Accession No. 0001193125-23-297130
Filing Date
2023-12-18
Accepted
2023-12-18 08:14:26
Documents
4

Document Format Files

Seq Description Document Type Size
1 SC 14D9/A d575580dsc14d9a.htm SC 14D9/A 21367
2 EX-99.(A)(5)(N) d575580dex99a5n.htm EX-99.(A)(5)(N) 24356
3 GRAPHIC g575580g1218074128447.jpg GRAPHIC 3083
4 GRAPHIC g575580g1218074128634.jpg GRAPHIC 2999
  Complete submission text file 0001193125-23-297130.txt   56213
Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (317) 543-9957
POINT Biopharma Global Inc. (Filed by) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: SC 14D9/A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (317) 543-9957
POINT Biopharma Global Inc. (Subject) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: SC 14D9/A | Act: 34 | File No.: 005-91575 | Film No.: 231492272
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)